Inhibition of Human Immunodeficiency Virus Type-1 Concerted Integration by Strand Transfer Inhibitors Which Recognize a Transient Structural Intermediate

Institute for Molecular Virology, Saint Louis University Health Sciences Center, St. Louis, MO⁺ and Department of Antiviral Research, Merck Research Laboratories, West Point, PA

^* To whom correspondence should be addressed. Email: grandgdp{at}slu.edu.

	Abstract

Human immunodeficiency virus type-1 (HIV-1) integrase (IN) inserts the viral DNA genome into host chromosomes. Here, by native agarose gel electrophoresis, using recombinant IN with a blunt-ended viral DNA substrate, we identified the synaptic complex (SC), a transient early intermediate in the integration pathway. The SC consists of two donor ends juxtaposed by IN non-covalently. The DNA ends within the SC were minimally processed (15%). In a time-dependent manner, the SC associated with target DNA and progressed to the strand transfer complex (STC), the nucleoprotein product of concerted integration. In the STC, the two viral DNA ends are covalently attached to target and remain associated with IN. The diketo acid inhibitors and their analogs effectively inhibit HIV-1 replication by preventing integration in vivo. Strand transfer inhibitors L-870,810, L-870,812 and L-841,411, at low nM concentrations, effectively inhibited the concerted integration of viral DNA donor in vitro.The inhibitors, in a concentration dependent manner, bound to IN within the SC and thereby blocked the docking onto target DNA, which thus prevented the formation of the STC. Although 3'-OH recessed donor efficiently formed the STC, reactions proceeding with this substrate exhibited marked resistance to the presence of inhibitor, requiring significantly higher concentrations for effective inhibition of all strand transfer products. These results suggest that binding of inhibitor to the SC occurs prior to, during, or immediately after 3' OH processing. It follows that the IN-viral DNA complex is "trapped" by the strand transfer inhibitors via a transient intermediate within the cytoplasmic preintegration complex.